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Disproportionate health care spending among populations is a global phenomenon whereby a fraction of health care users, referred to as "high-cost users," represents an inordinate percentage of health care spending. The correlation between socioeconomic status (SES) and health care cost has been corroborated by many studies. 1, 2 The cost-use gradient associated with SES is attributed to discrepancies in the health-shaping conditions endured by different sociodemographic groups. 1 Clinical laboratory tests account for 3% of total health care spending in the United States. 3 This is exacerbated by the continual increase in clinical laboratory utilization. The volume of clinical chemistry, hematology, and microbiology laboratory tests has been increasing disproportionately to population growth at an unsustainable rate. 4 Inappropriate test ordering is a significant contributor to the increase in volume. [5] [6] [7] [8] Although some studies have looked into the utilization and costs of specific patient groups, 9, 10 to date there have not been any widespread investigations into the test volumes and costs for a general population.
In this study, we describe the sociodemographic correlates of clinical laboratory test costs for patients in the city of Calgary, Alberta. In addition, we demonstrate the geographic distribution of clinical laboratory costs using hotspot mapping. It is important to understand these relationships to predict future trends in test use and to inform potential utilization management strategies. The latter objective is particularly important given that 11 While it is known that misutilization costs comprise a significant proportion of clinical laboratory costs, there is not a clear understanding of whom these tests are being ordered for.
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Materials and Methods

Ethics Statement
This study was approved by the University of Calgary Conjoint Health Research Ethics Board.
Test Data
Data collected for this study were obtained from the laboratory information system of Calgary Laboratory Services (CLS). CLS is the solitary provider of clinical laboratory testing to the metropolitan city of Calgary, Alberta, Canada. The extracted data included all clinical laboratory tests performed within this region over the calendar year of 2011. The total population of the geographic area was 1.097 million. Clinical laboratory tests include clinical hematology, clinical chemistry, and clinical microbiology laboratory tests. Tests ordered by resident physicians and physicians from outside the Calgary zone were excluded. Patients were recruited into the data set if they used a minimum of one clinical laboratory test in the 2011 calendar year. This calendar year was chosen to correspond with the 2011 Canada population census (discussed below).
Calculation of Test Costs
A patient's total test utilization cost was estimated by adding the costs of each individual test taken by that patient. Each test cost was determined as previously described by using median test prices from 10 Canadian laboratories. 8 These prices were validated against internally estimated prices within our own laboratory and are assumed to be close approximations given Canada's publicly funded health care system. If a specific clinical laboratory test was not conducted at any of the 10 laboratories, its cost was estimated internally and averaged to the nearest whole dollar amount. For tests outsourced to other laboratories, the invoiced costs were used.
Population Analysis
The clinical test utilization cost of each patient was combined with group-level sociodemographic variables using the 2011 Canadian Household Survey from the Canada census as done previously [12] [13] [14] [15] [16] Along with their record of tests taken over the year, age, sex, and provincial health care numbers were extracted for each patient. Provincial health care numbers were used to obtain each patient's postal code from an Alberta Health Services database, and in turn, the postal codes were linked to the corresponding geographic coordinates and census dissemination areas assigned by Statistics Canada. Grouplevel sociodemographic variables were inferred at the census dissemination area level from the 2011 Canada census. These included postsecondary education, median household income, employment status, recent immigrant status (immigrated within the past 5 years), Aboriginal First Nations, Aboriginal Métis, and the three largest visible minorities: Chinese, South Asian, and black. Results of data for males were used as the baseline comparator. All ethnic groups not used in this model were used as reference for those groups. SAS version 9.2 (SAS Institute, Cary, NC) was used for statistical analysis. Linear mixed models with generalized estimating equations were used to test statistical significance.
Geographical Analysis
A geographical hotspot map was created by using ArcGIS software version 9.3 (ESRI, Redlands, CA) on the 1,590 dissemination areas defined for the Calgary region by Statistics Canada in the 2011 Canada census. Patients were assigned to a dissemination area through their postal code, and z scores were produced using the Getis-Ord Gi* statistic in ArcGIS to identify statistically significant high-and low-cost spots in each dissemination area according to standard deviations from the mean.
Results
A total of 610,409 patients received at least one laboratory test during the 2011 calendar year, representing 55.6% of Calgary's population at the time. The mean patient age was 43.4 years. Of the tested population, 58.4% were female and 41.6% were male. A total of 547 clinical laboratory tests were included in the study. The combined cost of all clinical laboratory tests administered over 1 calendar year was determined for each patient.
❚Table 1❚ shows the sociodemographic variables associated with patient test cost. Overall, women had lower annual laboratory costs than men (relative risk [RR], 0.94; P < .0001). Increasing age was significantly associated with increasing laboratory testing costs (RR, 1.01; P < .0001), although the effect size was small. There was no significant statistical difference in laboratory testing for recent immigrants (P = .54). Costs were higher for Aboriginal First Nations (RR, 1.27; P = .04), Aboriginal Métis (RR, 1.44; P = .02), visible minority "black" (RR, 1.40; P < .0001), and visible minority "South Asian" (RR, 1.16; P < .0001). Visible minority "Chinese" had lower test expenditures (RR, 0.82; P < .0001), as did people with employment (RR, 0.84; P < .0001) and university education (RR, 0.92; P = .009). Median household income was a significant variable, with every increase of $100,000 in household income reducing clinical laboratory costs by two-thirds (RR, 0.34; P = .0001).
❚Figure 1❚ shows the geographic area of the city of Calgary and surroundings colored according to test costs per patient. There was an obvious geographic variation in different areas of the city with regions of high and low test costs in red and blue, respectively. In general, the hotspot analysis demonstrates that the patients living on the periphery of the city had higher test utilization costs than patients living centrally. More specifically, the hotspots were most extreme in the southeastern, northeastern, and central north areas, and the cold spots were located in the downtown and inner-city disseminations areas.
Discussion
In this article, we present the first evaluation of an entire major city's patient health care costs for clinical laboratory tests encompassing chemistry, hematology, and microbiology. The correlation of this data to sociodemographic variables and geographic region may be useful for public health planning and managing laboratory test utilization.
Our results are in general agreement with the findings outlined in the World Health Organization's Social Determinants of Health Model (SDHM), which describes the relationship between sociodemographic factors and the burden of disease. 17 More specifically, it predicts that poor health outcomes are influenced by variables such as low income, low employment rate, female sex, and minority status. In addition, we found that patients who lived on the periphery of the city have higher annual clinical laboratory costs than people who live in the downtown core. Our study highlights the health inequity between patients with high and low incomes. This is shown most profoundly with our analysis of household income where it was found that with every increase of $100,000, clinical laboratory costs decrease by two-thirds. This is not surprising as studies have shown that middle-aged adults living in an upper-middle or high-income household have an increased likelihood of staying healthy. 18 Income has a direct influence on other social determinants of health such as food security and housing, and it has an association with health-related behaviors such as diet, physical activity, tobacco use, and excessive alcohol usage. 18 Although not as remarkable, employment status is associated with lower annual clinical laboratory costs. Not only does employment provide financial security, but it also provides purpose, identity, opportunity for personal growth, and social status. There is an association between the loss of these benefits and adverse health outcomes. 19 As well, those who received postsecondary education had lower clinical laboratory costs. Altogether, household income, employment status, and postsecondary education are interdependent variables that contribute to a person's SES and thus affecting his or her health. 20 Recent immigrants were not found to have statistically different test costs. Although immigrant populations tend to have lower SES, there is a "healthy immigrant effect" whereby recently arrived immigrants enjoy better health compared with nonimmigrants. 21 This is mostly attributed to the medical screening requirements of the immigration process. Furthermore, many immigrants to Canada have not yet settled into lifestyle behaviors that contribute to chronic conditions related to diet, inactivity, and obesity. 22 Following immigration, there is a decline in health that can take from 4 to 10 years of residence to reach levels below those experienced by nonimmigrants. 23, 24 Following this health decline, proper access to Canadian health services becomes a major challenge facing immigrants. 25 The test costs reported here for patients who have immigrated no more than 5 years do not reflect the benefits of the healthy immigrant effect. This may be due to its short period of influence, and health discrepancies between subgroups are not reflected here (eg, skilled vs refugees). 26 However, this result does help to dispel some of the flawed assumptions regarding immigrant patients' overuse of medical services.
Higher clinical laboratory costs were found in the South Asian and black visible minority groups but not with the visible minority Chinese. Higher costs were expected, as poor health and high burden of disease are associated with minority communities. Visible minorities endure a range of adverse economic and social conditions that challenge their health. These include but are not limited to social exclusion, high unemployment, and underemployment. 27 Aboriginal and Métis First Nation populations also experience health-determining inequalities and as a result have high rates of chronic disease such as diabetes. 28 This is a global trend whereby Canadian Aboriginals, Aboriginal Australians, New Zealand Māori, and Native Americans all have high rates of morbidity and mortality. 29 The lower annual laboratory costs for the visible minority Chinese do not align with the rationale that poorer health is correlated with minority populations. Although Chinese immigrants generally report poorer health than Canadian-born people in self-assessments and do not benefit as greatly from the healthy immigrant effect, 30 ,31 many individuals may have a different approach to health care that emphasizes traditional Chinese medicine (TCM). The perceived advantages of TCM include an emphasis on prevention, lower cost, less intrusive and safer treatments, dealing with both the symptom and root of disease, and overall effectiveness for a variety of diseases and illnesses. 32, 33 Also, many Chinese immigrants tend to seek Chinese-speaking physicians to overcome language and cultural barriers. The lengthy search period further contributes to their underutilization of the Canadian health care system. 34 Consequently, they undergo less testing than nonimmigrants despite a higher burden of disease, 35, 36 but this is not the case for all clinical tests. 37 Although women live longer than men, they experience poorer health and have more adverse health-shaping experiences than men. 38, 39 Thus, it was unexpected that, although women comprised a larger section of patients who undergo laboratory testing, they have lower average test costs than men. Women generally visit their general practitioners and specialists more often than men. 40 It is possible that when men visit the doctor, it is more often for serious ailments that require more clinical laboratory testing.
Our results indicate that patients who live in the periphery of the city have higher annual clinical laboratory costs relative to those who live in the city's core. This pattern is likely due to the new communities that have emerged at the city's edge. These communities offer more affordable housing and likely attract lower-income families. Conversely, the housing in the city's core is more expensive and is likely to attract people with a higher income. As the SDHM depicts, a higher household income is often related to higher education and a higher employment rate. Although there is partial overlap between the hotspot areas with lower SES, the association is complicated by considerable variation in other factors among neighborhoods.
This study has limitations. First, patients who did not receive any clinical laboratory testing in 2011 were not included in the study. Therefore, our results reflect the average costs for the proportion of the sociodemographic groups that get clinical testing rather than for entire groups. This limitation is exemplified by the sex disparities calculated here, whereby more women undergo testing than men but men on average have higher testing costs. Second, our study only looks at clinical laboratory tests. It does not consider genetic tests, anatomic pathology tests, cytology, or bone marrow tests. Furthermore, point-of-care testing such as dipstick and glucose meter testing was not included. Although it is infeasible for this study, the inclusion of these tests would provide a more accurate evaluation of patients' health-testing expenditures.
Future work in this area may involve looking at the sociodemographics of the physicians who are ordering the clinical laboratory tests. Information such as race, age, religious beliefs, and geographic location may be informative. Investigation into the physician's medical school and residency program may also provide insight into why some physicians order more tests than others. The information we attained in this study will be informative for physicians ordering clinical laboratory tests as well as for widespread policy planners to reduce utilization costs and provide better health care for populations.
